| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/25/2011 | CN102070608A 4-substituted phenylamino-7-substituted alkoxy-quinazoline derivant and preparation method and application thereof |
| 05/25/2011 | CN102070607A Pyridine-n-oxide anabasine compound with insecticidal activity, and application thereof |
| 05/25/2011 | CN102070606A New method for preparing LenalidomideA crystal form |
| 05/25/2011 | CN102070605A Imatinib mesylate polymorph and pharmaceutical composition |
| 05/25/2011 | CN102070604A Method for preparing imatinib free alkali |
| 05/25/2011 | CN102070525A Tetrahydroisoquinoline derivatives and preparation method and application thereof |
| 05/25/2011 | CN102070522A Quinolone derivatives and application thereof in organic light-emitting devices (OLEDs) |
| 05/25/2011 | CN102067838A Amide fragment-containing (Z) type nitenpyram analogue pesticide and preparation method thereof |
| 05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 05/25/2011 | CN101374814B Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 05/25/2011 | CN101374808B Indole sulfonamide modulators of progesterone receptors |
| 05/25/2011 | CN101213184B Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 05/25/2011 | CN101160308B Pharmacetically acceptable salt with decoquinate ketone compound with improved medicine performance |
| 05/25/2011 | CN101137371B Process for preparing lansoprazole |
| 05/25/2011 | CN101061109B Novel pyridonecarboxylic acid derivatives or salts thereof |
| 05/25/2011 | CN101014576B Aryl spirolactam cgrp receptor antagonists |
| 05/24/2011 | US7947840 Process for preparation of enantiomerically pure esomeprazole |
| 05/24/2011 | US7947835 Certain substituted amides, method of making, and method of use thereof |
| 05/24/2011 | US7947832 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines |
| 05/24/2011 | US7947713 Tripeptidyl peptidase inhibitors |
| 05/24/2011 | US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/24/2011 | US7947700 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/24/2011 | US7947686 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors |
| 05/24/2011 | US7947684 anticoagulants; immunomoderators; antiinflammatory agents |
| 05/24/2011 | US7947683 3-(1,2,4-triazol-3-ylalkyl) azabicyclo (3.1.0) hexane derivatives as modulators of dopamine D3 receptors |
| 05/24/2011 | US7947680 Adamantyl diamide derivatives and uses of same |
| 05/24/2011 | US7947677 Spirolactam tricyclic CGRP receptor antagonists |
| 05/24/2011 | US7947513 Sets and compositions pertaining to analyte determination |
| 05/24/2011 | CA2510170C 3-substituted-4-pyrimidone derivatives |
| 05/24/2011 | CA2504663C Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases |
| 05/24/2011 | CA2499690C Diaryl ethers as opioid receptor antagonist |
| 05/24/2011 | CA2494047C Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles |
| 05/24/2011 | CA2493026C Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines |
| 05/24/2011 | CA2490888C Diaminopyrimidinecarboxamide derivative |
| 05/24/2011 | CA2463626C Piperidine- and piperazineacetamines as 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2303428C .alpha.-ketoamide multicatalytic protease inhibitors |
| 05/19/2011 | WO2011059887A1 Hepatitis c virus inhibitors |
| 05/19/2011 | WO2011059048A1 Novel amide derivative |
| 05/19/2011 | WO2011059042A1 Aromatic ring compound |
| 05/19/2011 | WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers |
| 05/19/2011 | WO2011058569A1 Process for the resolution of omeprazole |
| 05/19/2011 | WO2011058139A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
| 05/19/2011 | WO2011058113A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors |
| 05/19/2011 | WO2011057973A1 Oxazoline derivatives for treatment of cns disorders |
| 05/19/2011 | WO2011057461A1 Organic materials and organic electroluminescent apparatuses using the same |
| 05/19/2011 | WO2011017342A3 Mesoionic pesticides |
| 05/19/2011 | WO2011015524A3 Fungicide heterocycles derivatives |
| 05/19/2011 | WO2010151740A4 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases |
| 05/19/2011 | WO2010111634A3 Renin inhibitors |
| 05/19/2011 | US20110118471 Method for producing an intermediate product of dabigatran etexilate |
| 05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
| 05/19/2011 | US20110118438 Cyanine-type compounds having an alkynyl linker arm |
| 05/19/2011 | US20110118320 Substituted pyrroles and methods of use |
| 05/19/2011 | US20110118318 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| 05/19/2011 | US20110118314 Piperidine analogs as glycogen synthase activators |
| 05/19/2011 | US20110118311 Azole compound |
| 05/19/2011 | US20110118301 Amino-Aza-Adamantane Derivatives and Methods of Use |
| 05/19/2011 | US20110118291 Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase |
| 05/19/2011 | US20110118290 Novel Amides and Thioamides as Pesticides |
| 05/19/2011 | US20110118289 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands |
| 05/19/2011 | US20110118283 Substituted Pyrrolidine-2-Carboxamides |
| 05/19/2011 | US20110118282 Soluble Guanylate Cyclase Activators |
| 05/19/2011 | US20110118281 Compounds for inflammation and immune-related uses |
| 05/19/2011 | US20110118280 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof |
| 05/19/2011 | US20110118278 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs |
| 05/19/2011 | US20110118266 Derivatives of triazines and uracils, their preparation and their application in human therapeutics |
| 05/19/2011 | US20110118262 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors |
| 05/19/2011 | US20110118261 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 05/19/2011 | US20110118260 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group |
| 05/19/2011 | US20110118259 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/19/2011 | US20110118258 Quinazolin-oxime derivatives as hsp90 inhibitors |
| 05/19/2011 | US20110118252 Substituted amide derivatives and methods of use |
| 05/19/2011 | US20110118250 Beta-secretase modulators and methods of use |
| 05/19/2011 | US20110118248 Heteroaryl sulfonamides and CCR2/CCR9 |
| 05/19/2011 | US20110118246 Novel Compounds |
| 05/19/2011 | US20110118245 Raf kinase modulator compounds and methods of use thereof |
| 05/19/2011 | US20110118244 Factor xa inhibitors |
| 05/19/2011 | US20110118241 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2 |
| 05/19/2011 | US20110118236 Heterocyclic compound |
| 05/19/2011 | US20110118232 Pyrimidine compounds and use thereof |
| 05/19/2011 | US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases |
| 05/19/2011 | US20110118148 Nuclear magnetic resonance assembly of chemical entities using advanced antenna probes |
| 05/19/2011 | US20110118122 Insecticidal pyridine compounds |
| 05/19/2011 | US20110117659 Quinazoline-containing kits for labeling aldehyde or ketone moieties |
| 05/19/2011 | US20110117084 Vandetanib derivatives |
| 05/19/2011 | US20110117081 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 05/19/2011 | US20110113572 Specific naphthalmide-type dyes, dye composition comprising at least one such dye, process using same and uses |
| 05/19/2011 | CA2789879A1 Dimeric smac mimetics |
| 05/19/2011 | CA2781056A1 Kinase inhibitors |
| 05/19/2011 | CA2780892A1 Kinase inhibitors |
| 05/19/2011 | CA2780812A1 Hepatitis c virus inhibitors |
| 05/19/2011 | CA2780568A1 Oxazoline derivatives for treatment of cns disorders |
| 05/19/2011 | CA2780031A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
| 05/18/2011 | EP2322521A1 Heteroaryl compounds useful as inhibitors of GSK-3 |
| 05/18/2011 | EP2322507A1 Matrix metalloproteinase inhibitors |
| 05/18/2011 | EP2322506A1 Histamine H3 receptor agents, preparation and therapeutic uses |
| 05/18/2011 | EP2322505A1 1-adamantylazetidin-2-one derivative and pharmaceutical preparation comprising same |
| 05/18/2011 | EP2322222A1 Therapeutic agent for irritable bowel syndrome |
| 05/18/2011 | EP2321300A1 Chlorophyll catabolites |